Windermere, Florida, United States The company was established in North America in United States. The leading representative office of defined VC is situated in the Windermere.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Tavistock Life Sciences, startups are often financed by 5AM Ventures, Versant Ventures, Third Rock Ventures. The meaningful sponsors for the fund in investment in the same round are 5AM Ventures, Versant Ventures, Maverick Ventures. In the next rounds fund is usually obtained by Versant Ventures, 5AM Ventures, Maverick Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as E-Commerce, Health Care. Among the most popular portfolio startups of the fund, we may highlight Kalypsys, MethylGene, Ambrx. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Speaking about the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2015. The important activity for fund was in 2006. This Tavistock Life Sciences works on 7 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Athena Technology Ventures | California, Palo Alto, United States |
| Bright Success Capital | China, Hong Kong, Hong Kong Island |
| Charles Schwab Investment Management | California, San Francisco, United States |
| Charleston Angel Conference | - |
| COLOROOM | Beijing, Beijing, China |
| Fox Networks Group | California, Los Angeles, United States |
| Jiuhe Venture Capital | - |
| KOWN | Bulgaria, Grad Sofiya, Sofia |
| Leverate Media | Berlin, Berlin, Germany |
| Merck Animal Health Ventures | Madison, New Jersey, United States |
| Parinama Cultural Development Foundation | - |
| The Searle Funds at the Chicago Community Trust | - |
| Theta Capital | - |
| Treeline, Inc. | Massachusetts, United States, Wakefield |
| Venustech | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Poseida Therapeutics | $30M | 03 Apr 2018 | San Diego, California, United States | ||
Avidity Biosciences | $16M | 05 Jan 2017 | San Diego, California, United States | ||
G1 Therapeutics | $47M | 11 May 2016 | Durham, North Carolina, United States | ||
Syndax Pharmaceuticals | $80M | 24 Aug 2015 | Massachusetts, United States | ||
Blueprint Medicines | $50M | 12 Nov 2014 | Cambridge, Massachusetts, United States | ||
Nexvet | $31M | 16 Apr 2014 | Victoria | ||
Kalypsys | $100M | 29 Nov 2006 | San Diego, California, United States | ||
Ambrx | $52M | 05 Jul 2006 | San Diego, California, United States | ||
Ambrx | $5M | 25 Jan 2006 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Poseida Therapeutics | $30M | 03 Apr 2018 | San Diego, California, United States | ||
Avidity Biosciences | $16M | 05 Jan 2017 | San Diego, California, United States | ||
G1 Therapeutics | $47M | 11 May 2016 | Durham, North Carolina, United States | ||
Syndax Pharmaceuticals | $80M | 24 Aug 2015 | Massachusetts, United States | ||
Blueprint Medicines | $50M | 12 Nov 2014 | Cambridge, Massachusetts, United States | ||
Nexvet | $31M | 16 Apr 2014 | Victoria | ||
Kalypsys | $100M | 29 Nov 2006 | San Diego, California, United States | ||
Ambrx | $52M | 05 Jul 2006 | San Diego, California, United States | ||
Ambrx | $5M | 25 Jan 2006 | San Diego, California, United States |
